Enhance Care
with Genetic Insignts
with Genetic Insignts
We’re dedicated to helping people live their best days by helping them better understand their genome with GENETICSNOW®
Guidance
Doctor/Patient Support
Family planning
Useful for future family planning
Early Intervention
Early Diagnosis
Bringing solutions to genetic testing.
GoPath's GeneticsNow® Series includes a collection of next-generation sequencing panels that detect germline variants associated with an increased risk for various hereditary cancers. Our germline tests are clinical grade, with fast turnaround times and actionable results. We also have in-house contracted genetic counselors to aid in the interpretation of results and to provide guidance to patients.
This COMPREHENSIVE GERMLINE PANEL analyzes 88 clinically-relevant genes that are associated with genetic disorders, including most hereditary cancers.
PROSTATENOW is a germline test for people with prostate cancer. This test can be used to predict prognosis among men with localized prostate cancer, predict therapeutic responses for advanced patients, and predict cancer risk among unaffected men.
There is an increased likelihood of a BRCA1 or BRCA2 mutation in patients with certain personal and family history characteristics and various clinical criteria. BRCANOW is a Next-Gen Sequencing (NGS)-based assay using a state-of-the-art platform to detect whether or not a mutation is present.
LYNCHNOW is a cost-effective, screening tool that rapidly detects mutations that cause Lynch syndrome.
DIABETESNOW has a large database of previously tested patients to ensure highly validated, accurate, and informative result interpretation.
Our foundation is innovation.
We employ the best team, utilize the latest molecular technology and techniques, and build collaborations with key innovation partners.
